LIP
NEO icon

Lighthouse Investment Partners’s NeoGenomics NEO Stock Holding History

Lighthouse Investment Partners’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,098
Closed -$171K – 879
2026
Q1 		$171K Sell
23,098
-76,532
-77% -$805K 0.01% 660
2025
Q4 		$1.17M Buy
+99,630
New +$1.07M 0.04% 451

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Lighthouse Investment Partners's NEO Position: Q2 2026 in Review

Lighthouse Investment Partners sold out of NeoGenomics (NEO) in Q2 2026, closing a stake of 23,098 shares — an estimated $171K sold.

Lighthouse Investment Partners first reported a position in NEO in Q4 2025 and held it in 2 quarters. The position peaked at $1.17M in Q4 2025. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Lighthouse Investment Partners reported no remaining NeoGenomics position as of Q2 2026 after selling out during the quarter.
  • Lighthouse Investment Partners sold 23,098 NeoGenomics shares in Q2 2026, an estimated $171K.
  • Lighthouse Investment Partners first reported a position in NeoGenomics in Q4 2025 and held it in 2 quarters.
  • Lighthouse Investment Partners's NeoGenomics position peaked at $1.17M in Q4 2025.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Lighthouse Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.